Blue Trust’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Other funds holding AXSM
Blue Trust's AXSM Position: Q3 2026 in Review
Blue Trust held its Axsome Therapeutics (AXSM) position steady in Q3 2026 at 4 shares worth $738. The position accounts for ﹤0.01% of the portfolio, ranked #2222.
Blue Trust first reported a position in AXSM in Q4 2023 and has held it in 9 quarters since. The position peaked at $13.2K in Q1 2025. 359 funds tracked by Wall St. Rank hold AXSM as of Q3 2026.
- Blue Trust held 4 shares of Axsome Therapeutics worth $738 as of Q3 2026.
- Blue Trust left its Axsome Therapeutics share count unchanged in Q3 2026.
- Axsome Therapeutics made up ﹤0.01% of Blue Trust's portfolio in Q3 2026, its #2222 holding.
- Blue Trust first reported a position in Axsome Therapeutics in Q4 2023 and has held it in 9 quarters since.
- Blue Trust's Axsome Therapeutics position peaked at $13.2K in Q1 2025.
- 359 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.